SERUM miR-214 AS A NOVEL NONINVASIVE BIOMARKER FOR ANKYLOSING SPONDYLITIS

被引：0
|
作者：
Jin, S. H. [1 ]
Kook, H. [1 ]
Jin, H. M. [1 ]
Cho, Y. N. [1 ]
Lee, S. S. [1 ]
Park, Y. W. [1 ]
Kim, T. J. [1 ]
机构：
[1] Chonnam Natl Univ, Med Sch & Hosp, Dept Rheumatol, Res Inst Med Sci, Gwangju, South Korea
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P49
引用
收藏
页码：718 / 719
页数：2
相关论文
共 50 条
  • [1] Serum miR-214 as a novel biomarker for ankylosing spondylitis
    Kook, Hyun Yi
    Jin, So-Hee
    Park, Pu-Reum
    Lee, Seung-Jin
    Shin, Hong-Joon
    Kim, Tae-Jong
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (07) : 1196 - 1201
  • [2] Serum miR-3620-3p as a Novel Biomarker for Ankylosing Spondylitis
    Lee, Hae-in
    Park, Ki-jeong
    Kim, Hui-Ju
    Choi, Ah-Ra
    Jin, So-Hee
    Kim, Tae-Jong
    JOURNAL OF RHEUMATIC DISEASES, 2022, 29 (01): : 33 - 39
  • [3] Serum miR-214 Serves as a Biomarker for Prodromal Parkinson's Disease
    Li, Lanting
    Ren, Jingru
    Pan, Chenxi
    Li, Yuqian
    Xu, Jianxia
    Dong, Hui
    Chen, Yong
    Liu, Weiguo
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [4] miR-214 stimulated by IL-17A regulates bone loss in patients with ankylosing spondylitis
    Liu, Zizhong
    Huang, Feng
    Luo, Gui
    Wang, Yiwen
    Du, Ruikai
    Sun, Weijia
    Li, Jianwei
    Yuan, Xinxin
    Cao, Dengchao
    Li, Yuheng
    Liu, Caizhi
    Liang, Shuai
    Jin, Xiaoyan
    Ling, Shukuan
    Wang, Deqing
    Li, Yingxian
    RHEUMATOLOGY, 2020, 59 (05) : 1159 - 1169
  • [5] Identification of Serum miR-146a and miR-155 as Novel Noninvasive Complementary Biomarkers for Ankylosing Spondylitis
    Qian, Bang-ping
    Ji, Ming-liang
    Qiu, Yong
    Wang, Bin
    Yu, Yang
    Shi, Wei
    Luo, Yong-feng
    SPINE, 2016, 41 (09) : 735 - 742
  • [6] miR-214: a potential biomarker and therapeutic for different cancers
    Sharma, Tanu
    Hamilton, Ryan
    Mandal, Chandi C.
    FUTURE ONCOLOGY, 2015, 11 (02) : 349 - 363
  • [7] Hemolysis-free plasma miR-214 as novel biomarker of gastric cancer and is correlated with distant metastasis
    Zhang, Ke-Cheng
    Xi, Hong-Qing
    Cui, Jian-Xin
    Shen, Wei-Song
    Li, Ji-Yang
    Wei, Bo
    Chen, Lin
    AMERICAN JOURNAL OF CANCER RESEARCH, 2015, 5 (02): : 821 - 829
  • [8] Loss of regulation of β-Catenin expression by miR-214 and oncogenic role of miR-214 in metastatic melanoma cells
    Prabhakar, Kirthana
    Jayanthy, Ashika
    Setaluri, Vijay
    CANCER RESEARCH, 2017, 77
  • [9] The role of miR-214 in cardiovascular diseases
    Zhao, Yanfang
    Ponnusamy, Murugavel
    Zhang, Lei
    Zhang, Yuan
    Liu, Cuiyun
    Yu, Wanpeng
    Wang, Kun
    Li, Peifeng
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 816 : 138 - 145
  • [10] Increased serum levels of miR-214 in patients with PCa with bone metastasis may serve as a potential biomarker by targeting PTEN
    Fang, Yi
    Qiu, Jun
    Jiang, Zong-Bin
    Xu, Sheng-Rong
    Zhou, Zeng-Hua
    He, Rui-Lin
    ONCOLOGY LETTERS, 2019, 17 (01) : 398 - 405
12345